Diamante: Funding, Investors & Team (Sep 2026)
A biotech business called DIAMANTE (Nano-Technologies for Autoimmune Disease) is dedicated to using plants to create compounds with significant added value. The business received funding in 2016 to research novel diagnostic tools for autoimmune diseases, and as we move closer to therapeutic applications, The development of novel therapeutic approaches for autoimmune illnesses based on the restoration of self-tolerance using plant viruses exhibiting immunodominant peptides is our company's value proposition as a female-run business that values innovation. Diamante has made significant advancements in the field of Rheumatoid Arthritis diagnosis thanks to the Regione Veneto and in particular the national grant POR FESR AZIONE 111 2020/2021. (RA)
Diamante has raised $640k across 1 funding round on record, the most recent a Seed of $640k announced in Jan 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Diamante Company Profile and Key Stats
Latest funding round on record: Jan 2023.
Diamante Funding Rounds
Diamante Founders and Leadership Team
No contact details are on record for this team yet.
Diamante Funding Compared to Other Biotechnology Startups
Diamante's latest round of $640k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Diamante in Biotechnology and Verona
Companies Similar to Diamante
NOUS is a biotech startup working on developing a new era of ingredients for Food&Beverage and Nutraceutical…
Yeastime's value proposition is its innovative retrofitting ultrasound technology, which accelerates…
Oraigo is a leading company in the development of innovative road safety technology, utilizing brain-computer…
FTnet is a digital platform in the pharmaceutical industry that employs advanced technology to connect…
Genoa Instruments is a cutting-edge startup focused on revolutionizing biomedical and health research using…
Resalis Therapeutics is focusing on addressing metabolic diseases by targeting a key regulator linked to…
CoRe is an Italian start-up, aimed at the study of new product and process solutions in the field of…
Established in 1999, PHSE is a leading provider of time-sensitive and temperature-controlled transport…
MOGU, an Italian-based European company, is dedicated to developing a variety of mycelium-based technologies…
Relicta developed a water-soluble, transparent and biodegradable plastic for packaging made from fish…
Diamante Funding FAQs
What does Diamante do?
A biotech business called DIAMANTE (Nano-Technologies for Autoimmune Disease) is dedicated to using plants to create compounds with significant added value. The business received funding in 2016 to research novel diagnostic tools for autoimmune diseases, and as we move closer to therapeutic applications, The development of novel therapeutic approaches for autoimmune illnesses based on the restoration of self-tolerance using plant viruses exhibiting immunodominant peptides is our company's value proposition as a female-run business that values innovation. Diamante has made significant advancements in the field of Rheumatoid Arthritis diagnosis thanks to the Regione Veneto and in particular the national grant POR FESR AZIONE 111 2020/2021. (RA)
How much funding has Diamante raised?
Diamante has raised $640k across 1 round on record. The most recent is a Seed of $640k announced in Jan 2023.
When did Diamante last raise funding?
Diamante's most recent funding round on record is a Seed of $640k, announced in Jan 2023.
Who is the CEO of Diamante?
Valentina Garonzi is listed as CEO at Diamante.
Where is Diamante headquartered?
Diamante is based in Verona, Veneto, Italy.
How many employees does Diamante have?
Diamante is in the 11-50 employee band.
How does Diamante's funding compare to other Biotechnology startups?
Diamante's latest round of $640k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Diamante Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Diamante is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.